These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 17540809

  • 1. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M.
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [Abstract] [Full Text] [Related]

  • 2. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 3. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
    Wikström AK, Larsson A, Eriksson UJ, Nash P, Olovsson M.
    Acta Obstet Gynecol Scand; 2008 Sep 07; 87(2):146-53. PubMed ID: 18231881
    [Abstract] [Full Text] [Related]

  • 4. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.
    J Matern Fetal Neonatal Med; 2014 Jul 07; 27(10):1038-48. PubMed ID: 24066977
    [Abstract] [Full Text] [Related]

  • 5. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.
    N Engl J Med; 2004 Feb 12; 350(7):672-83. PubMed ID: 14764923
    [Abstract] [Full Text] [Related]

  • 6. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov 12; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 7. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N, Naicker T, Rajakumar A, Moodley J.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep 12; 170(1):100-5. PubMed ID: 23806447
    [Abstract] [Full Text] [Related]

  • 8. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE.
    Am J Obstet Gynecol; 2007 Sep 12; 197(3):244.e1-8. PubMed ID: 17826405
    [Abstract] [Full Text] [Related]

  • 9. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI, Geahchan C, Wenger J, Raghuraman N, Berg A, Haddow H, Mckeon BA, Narcisse R, David JL, Scott J, Thadhani R, Karumanchi SA, Rana S.
    PLoS One; 2015 Sep 12; 10(5):e0126815. PubMed ID: 25965397
    [Abstract] [Full Text] [Related]

  • 10. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.
    Am J Obstet Gynecol; 2016 Jan 12; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [Abstract] [Full Text] [Related]

  • 11. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan 12; 49(1):22-5. PubMed ID: 24694913
    [Abstract] [Full Text] [Related]

  • 12. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM, Tran C, Kaitu'u-Lino TJ, Brennecke SP, Hiscock RJ, Hui L, Dane KM, Middleton AL, Cannon P, Walker SP, Tong S.
    BMC Pregnancy Childbirth; 2018 Aug 31; 18(1):354. PubMed ID: 30170567
    [Abstract] [Full Text] [Related]

  • 13. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA.
    Am J Obstet Gynecol; 2008 Apr 31; 198(4):428.e1-6. PubMed ID: 18191808
    [Abstract] [Full Text] [Related]

  • 14. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.
    JAMA; 2005 Jan 05; 293(1):77-85. PubMed ID: 15632339
    [Abstract] [Full Text] [Related]

  • 15. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.
    Clin Chem Lab Med; 2014 Aug 05; 52(8):1169-78. PubMed ID: 24535301
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion.
    Stepan H, Unversucht A, Wessel N, Faber R.
    Hypertension; 2007 Apr 05; 49(4):818-24. PubMed ID: 17261644
    [Abstract] [Full Text] [Related]

  • 17. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec 05; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.